An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data Source
Clinical trial NCT05368818 · COMPLETED
Trial details
- NCT number
- NCT05368818
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-07
- Primary completion
- 2021-05-06
- Enrollment
- 767
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.